Humans make critical decisions about nonhuman lab animals outside the lab: during breeding, transportation, and end-of-study protocols.

Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.

Data on certain chronic conditions’ prevalence, incidence of potentially preventable morbidity, and health-harming legal factors influence approaches to care.

MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability.

Expanding MLPs’ positive health impact requires secure funding.

Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD.

Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary.

Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities.

Dr Jim Withers and Dave Lettrich join Ethics talk to discuss how street outreach programs help mitigate harms of drug use among people experiencing homelessness.

Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population.